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Abstract: 
Background: 
Households appear to be the highest risk setting for transmission of COVID-19. Large household 
transmission studies were reported in the early stages of the pandemic in Asia with secondary attack 
rates ranging from 5-30% but few large scale household transmission studies have been conducted 
outside of Asia. 
 
Methods: 
A prospective case ascertained study design based on the World Health Organization FFX protocol 
was undertaken in the UK following the detection of the first case in late January 2020. Household 
contacts of cases were followed using enhanced surveillance forms to establish whether they 
developed symptoms of COVID-19, became confirmed cases and their outcomes. Household 
secondary attack rates and serial intervals were estimated. Individual and household basic 
reproduction numbers were also estimated. The incubation period was estimated using known point 
source exposures that resulted in secondary cases. 
 
Results: 
A total of 233 households with two or more people were included with a total of 472 contacts. The 
overall household SAR was 37% (95% CI 31-43%) with a mean serial interval of 4.67 days, an R0 of 
1.85 and a household reproduction number of 2.33. We find lower secondary attack rates in larger 
households. SARs were highest when the primary case was a child. We estimate a mean incubation 
period of around 4.5 days. 
 
Conclusions: 
High rates of household transmission of COVID-19 were found in the UK emphasising the need for 
preventative measures in this setting. Careful monitoring of schools reopening is needed to monitor 
transmission from children. 
  
All rights reserved. No reuse allowed without permission. 
perpetuity. 
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 
The copyright holder for thisthis version posted August 22, 2020. ; https://doi.org/10.1101/2020.08.19.20177188doi: medRxiv preprint 
Introduction 
As of the end of July 2020, over 17 million cases of COVID-19 have been reported globally with over 
660,000 deaths (1). The causative agent, SARS-CoV-2, is primarily transmitted through the droplet 
and contact routes though aerosol and faecal transmission may also contribute (2, 3). 
 
Investigations of household transmission dynamics have been reported in China and other countries 
in Asia that experienced early cases (4-12). Households appear to be the highest risk setting for 
transmission with reported secondary attack rates (SARs) in household contacts ranging from 5% to 
30% (4-10). Rates of symptomatic infection increase with age and risk factors for more severe 
disease include age, male sex and a range of comorbidities (13, 14). Other than setting, risk factors 
for onwards transmission have not been well described. As countries move from broad social 
distancing measures to more targeted approaches, a detailed understanding of risk factors for 
transmission is increasingly important. 
 
In the UK the first cases of COVID-19 were reported in late January, the number of cases rapidly 
increased from March before plateauing, then declining after social distancing measures were 
introduced (13). We followed up the first few hundred (FF100) cases of COVID-19 in the UK and their 
household contacts. We have previously reported on the characteristics and outcomes of the cases 





We used a prospective case ascertained study design based on the World Health Organization FFX 
protocol (15).  
 
Ascertainment of cases and contacts 
The case ascertainment has been described in detail elsewhere (13). Briefly, in the early stages of 
the pandemic all PCR positive cases who met the case definition were followed up using enhanced 
surveillance forms on identification and after 14 days. This was later restricted to indigenous cases 
only. Cases were recruited from February to March 2020. 
 
Close contacts of confirmed cases were identified by the local Health Protection Team (HPT). Those 
considered at greatest risk, including household contacts, others with direct face to face contact and 
healthcare workers who had not worn recommended PPE were actively followed up on a daily basis 
for 14 days and asked about relevant symptoms. Household contacts were defined as those living or 
spending significant time in the same household. Other contacts not classified as close contacts were 
provided with health advice and advised to contact the HPT if they developed relevant symptoms. 
HPTs completed enhanced surveillance questionnaires to collect details from cases on  symptoms, 
medical history, details of the exposure, outcome and any virological tests (supplementary appendix 
1). A team of trained staff (health protection practitioners, nurses, doctors and field epidemiologists) 
proactively followed up all household contacts of confirmed cases 14 days or more after symptom 
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onset in the index case using telephone interviews to assess subsequent development of any 
symptoms and final outcomes (supplementary appendix 2). Contacts who developed symptoms 
compatible with COVID-19 were offered PCR testing as per national guidance (13). 
 
If cases or contacts were unable to be contacted by phone after at least two attempts, or if health 
protection teams had recorded a request for no further contact, they were classified as lost to 
follow-up. 
 
Details on other non-household community contacts were obtained through the HPZone public 
health management system. Community contacts with any point source exposures were included 
where there were no other suspected exposures and complete information was available on the 
timing of the exposure and symptom onset in the contact. Healthcare workers, returning travellers 
and airplane exposures were excluded. A detailed dataset was also maintained with information on 




Confirmed cases were those that tested positive for SARS-CoV-2 on PCR. Probable cases were those 
with fever, anosmia or respiratory symptoms. Those who had other unrelated or pre-existing 
illnesses were excluded. FF100 cases and household contacts were reclassified using date of 
symptom onset, to identify any primary cases that were initially recruited as contacts, and when 
secondary cases were due to household transmission. Households with two or more household 
members were included. The probable or confirmed case within the household with the earliest 
onset date was defined to be the primary household case. When two or more household members 
had the same earliest symptom onset dates these were defined as co-primary cases, as was any case 
with symptom onset the day after a primary case. 
All other subjects with later symptom onset dates were defined as a secondary case, apart from 
those that had symptom onset dates greater that 14 days after the primary case.  
Initial descriptive analyses were performed to explore the characteristics of the contacts. SARs and 
odds ratios for secondary transmission were estimated for a range of factors using univariate 
analyses and multivariate mixed effects logistic regression models with a random intercept for 
households. The following potential explanatory variables were examined: household size; 
characteristics of the contact, including: gender and age group; characteristics of the index case, 
including: gender, age, whether the case was admitted to hospital, and whether the symptoms 
included coughing or sneezing. Adjusted marginal SARs were estimated for each explanatory 
variable. Presence or absence of comorbidities among the primary case and contacts were explored 
as interaction terms. 
For the primary analyses co-primaries were excluded and SARs were based on confirmed and 
probable secondary cases. Three sensitivity analyses were undertaken: 1) with co-primaries 
included; 1) restricted to laboratory confirmed secondary cases only; 2) with probable confirmed 
and possible secondary cases, the latter included those who developed any non-respiratory 
symptoms (e.g. nausea, fatigue, joint aches) within 14 days of exposure . 
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Serial interval was defined as time from onset of first symptom in the primary cases to time of onset 
of first symptom in the secondary case with a cut off of 14 days. The same explanatory variables as 
in the SAR analysis were considered. A lag factor was added to account for cases who were not 
present the household at the time the symptoms of the corresponding index cases started and 
adjustment was also made for the number of cases in the household at the time of first exposure. 
Individual variables were initially explored using Kaplan-Meier estimates of the survival function. 
Survival regression was then undertaken using the best fitting of the Log-normal, Gamma or Weibull 
distributions. 
 
Individual basic reproduction number(R0) is estimated using the exponential growth model described 
by Wallinga and Lipsitch (2007) and the renewal equation model described by Fraser (2007) with 
adjustment for the contribution of imported cases (16, 17). We used the approach described by 
Fraser (2007) to estimate the household reproduction number (defined as the number of 
households infected by each infected household) (17). For estimates of reproduction number 
analyses were restricted to cases from the very early stages of the pandemic when all identified 
cases were included in the FF100. 
 
Community contacts 
The median incubation period was estimated for probable secondary cases and confirmed secondary 
cases who had a point source exposure. Exposures before the onset date in the index case were 
excluded. The timing of exposure among these cases was compared to timing of exposure among 
contacts that did not develop symptoms. Healthcare workers, returning travellers, airplane 
exposures and those who had contact with multiple cases were excluded from this analysis. 
 
Ethics 
This was an observational surveillance system carried out under the permissions granted under 
Regulation 3 of The Health Service (Control of Patient Information) Regulations 2020 and under 
Section 251 of the NHS Act 2006. 
 
Results 
Characteristics of cases 
The initial FF100 dataset consisted of 379 confirmed COVID-19 cases, 357 from England, 19 from 
Scotland and three from Wales, who developed symptoms between 24th January 2020 and 13th 
March 2020. Of the cases 199 were imported, 92 were secondary and 88 indigenous. There were 
slightly more males (56.7%) than females among the UK FF100 cases. Cases had a mean age of 47.7 
years (standard deviation (SD) 17.4) and ranged between 11 months and 94 years. We have 
previously reported details of these cases and their outcomes (13). 
 
Recruitment and follow-up of households 
After reclassification, there were 365 primary/co-primary cases residing in 329 homes. In 96 
households, the case was the only recorded resident. The remaining 269 primary/co-primary cases, 
resided in 233 homes. 32 households had two co-primary cases and two households had three co-
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primary cases. In 10 households the primary/co-primary case was under 19 years old.  472 
household contacts were identified, of these 32 (6.8%) were lost to follow-up, however 11 were 
linked to testing data (Figure 1). 135 household contacts developed either cough, fever or anosmia. 
Among those with tested after symptom onset with complete information on onset and test date 
the mean time from onset of symptoms to testing of these contacts was 2.9 days. 
 
  
Figure 1: Flowchart of COVID-19 case-patients and household contacts, including contacts with any respiratory symptoms, 
and contacts with at least one of cough, fever or anosmia, contacts from whom specimens were collected and RT-PCR 
result, United Kingdom, 2020. §16 persons had onset of symptoms >2 weeks after onset date in the primary case. *9 
persons had specimen date (or laboratory result date if specimen date not known) >2 weeks after primary case-patient 
symptoms onset and 4 had a positive test result. †2 persons (neither positive) had specimen date (or laboratory result date 
if specimen date not known) >2 weeks after primary case-patient symptoms onset. ‡1 person (not positive) had laboratory 
result date >2 weeks after primary case-patient symptoms onset. 
 
Household contact characteristics 
Characteristics of the household contacts are shown in Table 1. Household size ranged from 2 to 7 
people. The age of household contacts ranged from 3 months to 84 years, with a mean age of 29.7 
years (SD 19.9 years) and 241 (51.1%) were female. Comorbidity data was wholly or partially present 
for 437 household contacts, 60 (13.7%) of whom had an underlying health condition and 7 (1.6%) of 
whom had multimorbidity. The most frequent conditions were asthma and other respiratory 
disease. 
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Among contacts with complete follow-up the most common symptom was cough (26.1%), followed 
by fatigue (20.2%) and headache (19.5%) (supplementary figure 1). A response for anosmia was 
present for 287 contacts, of these 30 (10.5%) experienced anosmia. Of the contacts who developed 
fever, cough or anosmia 68.1% (92/135) were tested, with 54.3% (50/92) testing positive. Within the 
follow-up period 3.6% (16/440) of contacts were hospitalised, with a median duration of stay of 3.5 
days (IQR 2-9.5 days), all hospitalised contacts tested positive for SARS-CoV-2. None of the contacts 
with complete follow-up died during the study period. 







N  311 96 65 472 
  n(%) n(%) n(%) n(%) 
Lost to follow-up     
 Yes 24 (7.7) 3 (3.1) 5 (7.7) 32 (6.8) 
 No 287 (92.3) 93 (96.9) 60 (92.3) 440 (93.2) 
Household size     
 2 39 (12.5) 17 (17.7) 21 (32.3) 77 (16.3) 
 3 63 (20.3) 25 (26.0) 18 (27.7) 106 (22.5) 
 4 104 (33.4) 30 (31.2) 18 (27.7) 152 (32.2) 
 5 61 (19.6) 18 (18.8) 7 (10.8) 86 (18.2) 
 6 22 (7.1) 4 (4.2) 1 (1.5) 27 (5.7) 
 7 22 (7.1) 2 (2.1) 0 (0.0) 24 (5.1) 
Age      
 <19 133 (42.8) 33 (34.4) 9 (13.8) 175 (37.1) 
 19-64 166 (53.4) 63 (65.6) 50 (76.9) 279 (59.1) 
 >65 12 (3.9) 0 (0.0) 6 (9.2) 18 (3.8) 
Sex      
 Female 161 (51.8) 46 (47.9) 34 (52.3) 241 (51.1) 
 Male 150 (48.2) 50 (52.1) 31 (47.7) 231 (48.9) 
Comorbidities     
 Any comorbidity 30 (9.6) 13 (13.5) 17 (26.2) 60 (12.7) 
 
Asthma requiring 
medication 13 (4.2) 2 (2.1) 10 (15.4) 25 (5.3) 
 
Respiratory disease 
excluding asthma 5 (1.6) 3 (3.1) 2 (3.1) 10 (2.1) 
 Diabetes (%) 4 (1.3) 2 (2.1) 1 (1.5) 7 (1.5) 
 Heart disease 5 (1.6) 1 (1.0) 1 (1.5) 7 (1.5) 
 
Immunodeficiency 
(%) 4 (1.3) 1 (1.0) 1 (1.5) 6 (1.3) 
 Malignancy 0 (0.0) 3 (3.1) 2 (3.1) 5 (1.1) 
 
Neurological 
disease (%) 2 (0.6) 1 (1.0) 2 (3.1) 5 (1.1) 
 Kidney disease 2 (0.6) 1 (1.0) 1 (1.5) 4 (0.8) 
 Unknown 29 (9.3) 3 (3.1) 3 (4.6) 35 (7.4) 
*Non-cases: includes household contacts with no respiratory symptoms, contacts who developed respiratory symptoms 
>14 days after symptom onset in the primary case, and contacts with unrelated prior illnesses (identified through review of 
of household symptomology dates and HPZone case notes) 
**Outcome provided as a percentage of contacts with completed follow-up 
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Household transmission dynamics 
SARs 
The household secondary attack rate (SAR) was 37% (95% CI 31-43%) including  both confirmed or 
probable secondary cases. If restricted to confirmed secondary cases only the SAR was 16% (95% CI 
11-20%) and when possible, probable and confirmed secondary cases were included the SAR was 
43% (95% CI 0.37-0.49). 
Unadjusted SARs odds ratios of probable and confirmed secondary cases by a range of explanatory 
variables are shown in Table 2 and the multivariate analysis is shown in Table 3. In both the 
univariate and multivariate analyses, there was an inverse relationship between household size and 
SAR, with the highest SAR in households with 2 people (adjusted: 0.48, 95%CI 0.35-0.60) and the 
lowest in households of 5 or more (0.22, 95%CI 0.12-0.32). There were no significant effects of 
gender or presence of comorbidities in either primary case or contacts nor of presence of cough or 
sneezing as a symptom in the primary case. SARs were lowest in contacts aged under 18 years or 65 
years and over, however these effects were not significant. SARs were highest where the primary 
case was aged <18 years with a significantly higher odds of secondary infection (OR 61, 95% CI 3.3-
1133) however there were only 3 households with no coprimaries and a primary case aged under 18 
years and there is a lot of uncertainty in this finding. Where the primary case was admitted to 
hospital there was a significantly lower odds of secondary infection in the household (OR 0.5, 95% CI 
0.2-0.8). 
When co-primaries were included in the analysis, results were broadly similar, this increases the 
number of households with children as a primary and the odds of secondary infection remains 
significant (OR 8, 95% CI 1.3-49) (supplementary table 1). In the analysis restricted to laboratory 
confirmed secondary cases, there is a significantly lower odds of secondary infection in contacts 
aged <18 years (OR 0.22; 95% CI 0.01-0.87) and the higher odds of secondary infection where the 
primary case is aged <18 years remains (OR 22, 95% CI 1-464) (supplementary table 2). 
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Table 2: Unadjusted secondary attack rates and odds ratios for secondary infection (probable and confirmed secondary 
cases) 








 Household size 2 0.49 (0.37 - 0.60)   
3 0.41 (0.29 - 0.52) 0.62 (0.25 - 1.57) 
4 0.32 (0.22 - 0.42) 0.36 (0.14 - 0.91) 








Gender interactions M -> M 0.37 (0.25 - 0.49)   
M -> F 0.42 (0.33 - 0.51) 1.36 (0.62 - 2.97) 
F -> M 0.34 (0.25 - 0.44) 0.85 (0.33 - 2.19) 
F -> F 0.29 (0.17 - 0.41) 0.59 (0.19 - 1.79) 
Comorbidities none -> none 0.37 (0.29 - 0.45)   
none -> comorbidities 0.46 (0.30 - 0.61) 1.70 (0.64 - 4.55) 
comorbidities -> none 0.36 (0.25 - 0.47) 0.95 (0.40 - 2.21) 
comorbidities -> 
comorbidities 

















gender M 0.36 (0.29 - 0.43)   
F 0.38 (0.31 - 0.45) 1.15 (0.66 - 1.99) 
age group  <18 0.30 (0.22 - 0.38) 0.62 (0.29 - 1.34) 
18-34 0.37 (0.28 - 0.47)   
35-64 0.43 (0.35 - 0.51) 1.38 (0.68 - 2.81) 




















age group <18 0.89 (0.67 - 1.12) 41.89 (2.03 - 865.08) 
18-64 0.35 (0.29 - 0.41)   
65+ 0.42 (0.24 - 0.60) 1.51 (0.51 - 4.44) 
gender M 0.41 (0.33 - 0.48)   
F 0.33 (0.25 - 0.41) 0.61 (0.30 - 1.26) 
hospital admission without hosp. adm. 0.43 (0.36 - 0.51)   
with hosp. adm. 0.28 (0.20 - 0.36) 0.37 (0.18 - 0.77) 
cough sneezing without cough/sneeze 0.32 (0.18 - 0.46)   
with cough/sneeze 0.38 (0.32 - 0.44) 1.42 (0.52 - 3.85) 
 overall  0.37 (0.31 - 0.43) 0.46 (0.32 - 0.66) 
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Table 3: Adjusted secondary attack rates and odds ratios for secondary infection (probable and confirmed secondary cases) 








 Household size 2 0.48 0.35 0.6 1     
3 0.4 0.29 0.52 0.67 0.27 1.6 
4 0.33 0.23 0.44 0.46 0.18 1.1 

















Gender Male 0.36 0.28 0.43 1     
Female 0.32 0.24 0.39 0.8 0.44 1.5 
Age group <18 0.29 0.2 0.38 0.73 0.34 1.6 
18-34 0.34 0.24 0.44 1     
35-64 0.39 0.3 0.48 1.3 0.66 2.6 




















Gender Male 0.38 0.3 0.46 1     
Female 0.29 0.21 0.37 0.6 0.3 1.2 
Age group <18 0.92 0.75 1.1 61 3.3 1133 
18-64 0.31 0.25 0.37 1     
65+ 0.38 0.16 0.59 1.4 0.41 5.1 
Hospital 
admission 
without hospital adm. 0.4 0.33 0.48 1     
with hospital adm. 0.25 0.17 0.33 0.4 0.2 0.8 
Cough or 
sneezing 
no cough/sneeze 0.29 0.15 0.43 1     
cough/sneeze 0.34 0.28 0.41 1.4 0.54 3.4 
 
 
Serial interval in households 
The Weibull distribution provided the best fit for the univariate survival analysis and gave a mean 
serial interval of 4.67 days (further details in supplementary figure 2 and supplementary table 3). In 
the multivariate analysis, explanatory variables that were associated with a shorter serial interval 
included the primary case experiencing cough as a symptom and the primary case being an imported 
case (Table 4). There were non-linear relationships between both age of index case and age of 
household contact and serial interval with shorter serial intervals if the index case was a child or an 
older adult compared to working age adults and a longer serial interval among household contacts 
who were children or older adults compared to working age adults (supplementary figure 3). Crude 
serial intervals and modelled effect of age as a continuous variable are provided in supplementary 
table 4 and supplementary figure 2 respectively. 
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Table 4: Adjusted serial intervals using marginal means and hazard ratios 
 Variable Levels 
Serial 










No 5.99 4.67 7.69 1   
Yes 4.75 3.57 6.33 1.4 0.96 2.04 
Cough 
No 6.79 4.96 9.30 1   
Yes 5.04 3.96 6.41 1.55 1.06 2.26 
Fever 
No 4.5 3.48 5.81 1   
Yes 5.73 4.42 7.43 0.7 0.50 1.00 
Age 
group 
<18 4.04 2.73 5.96 1.5 0.89 2.54 
18-64 5.34 4.22 6.75 1   
65+ 6.59 3.82 11.38 0.73 0.35 1.54 
Gender 
Male 5 3.93 6.37 1   









<18 5.14 4.33 6.10 1.06 0.7 1.59 
18-34 5.34 4.22 6.75 1   
35-64 4.48 3.6 5.58 1.29 0.87 1.91 




Basic and household reproduction number 
Using the approach by Wallinga and Lipsitch (2007), and based on the serial interval above, we 
obtained an estimate of R0: 3.67 (95%CI: 3.22–3.98). Using the renewal equation to take into 
account the contribution of imported cases, individual R0 in the early stages of the pandemic in the 
UK is estimated at 1.85 (95% CI: 1.20-3.42). Applying the household transmission model to the 
household data, we found that the average total number of cases in an infected household is 1.67. 
The household reproduction number from the same models is estimated at 2.33 (95%CI 1.30-4.89). 
 
Community contacts 
45 confirmed or probable secondary cases were identified that had a point source exposure 
(exposure window of maximum one day) to a primary case in the FF100 dataset, of these 12 were 
laboratory confirmed secondary cases. The median incubation period for confirmed and probable 
cases with a point source exposure was 4.51 days (SD 2.66), for confirmed secondary cases alone it 
was 4.77 days (SD 2.34) (Table 5). Probable and confirmed secondary cases were exposed a mean of 
2.37 days (SD 3.36) after symptom onset in the index case, ranging from 0-14 days. Restricting to 
confirmed secondary cases alone, exposure was mean 1.33 days (SD 1.61) after symptom onset in 
the primary case, ranging from 0-5 days). This compares to 2.71 days among contacts who didn’t go 
on to become a case. Further details of the timing of onset and exposure for the confirmed 
secondary cases are shown in supplementary figure 4. 
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Table 5: Summary of incubation period and timing of exposure in relation to primary case symptom onset for contacts with 
a point source exposure. 
 Incubation period (days) 
Timing of exposure after symptom onset of primary 
case (days) 
Status of contact 
Number of 
contacts 
included Mean SD Median IQR Range Mean SD Median IQR Range 
Probable and confirmed 
secondary cases 45* 4.51 2.66 4 2 
 
- 7 0 
 
- 11 2.37 3.36 1 0 
 
- 4 0 
 
- 14 
Confirmed secondary cases 12 4.75 2.34 4 3.75 
 
- 5 2 
 
- 11 1.33 1.61 1 0 
 
- 1.25 0 
 
- 5 
Did not develop symptoms  241  -  -  -  
 
-   
 
-  2.71 2.74 2 0 
 
- 5 0 
 
- 9 




In the UK, prior to the implementation of social and physical distancing measures, we estimate an 
overall household SAR of 37%, a serial interval of 4.67 days, an R0 of 1.85 and a household 
reproduction number of 2.33. We find lower secondary attack rates in larger households. There is 
some suggestion that where the primary case is a child, household SARs are higher and the serial 
interval is shorter. Conversely serial intervals were longer if the household contact was a child or an 
older adult. Using point source exposures we estimate a mean incubation period of around 4.5 days. 
 
Our estimated household SAR in the UK is greater than that reported in China, Taiwan and South 
Korea estimated household SARs ranging from 5% to 30% (4-10). Making comparisons across studies 
is challenging due to differences in follow-up, symptom ascertainment or testing of contacts, 
however, the higher household SAR in the UK could reflect differences in isolation and infection 
control measures taken to reduce spread. In the UK, individuals meeting the case definition were 
advised to minimise contact with others in the household, wash hands regularly and cover coughs 
and sneezes. This is broadly similar to advice issued elsewhere, though more stringent advice on 
quarantine within the household and wearing masks was in place in some areas, and cases were 
taken out of the household and placed in isolation facilities (4, 8). It is also possible that timing of the 
diagnosis of secondary cases was more delayed in the very earliest stages of the pandemic in China 
and other countries that experienced early cases, when less was understood about the disease. Our 
serial interval estimate is broadly similar to previous estimates that range from 4.0 to 6.3 days.(4, 
18-20). 
 
This high estimated R0 using the Wallinga and Libsitch (2007) approach is because the method has 
neglected the contribution of cases that continuously imported from abroad to transmission 
dynamics in UK. After adjusting for the contribution of imported cases , the R0 is lower than existing 
estimates obtained for the early stage in China, though confidence intervals overlap (21-24).  
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We estimated a mean incubation period of 4.51-4.75 days, slightly lower than previous estimates 
which range from 5.5 to 6.4 days (25-27). Previous estimates have been based on estimated 
distributions using earliest and latest exposure period. In our analysis we restricted to those with 
unique point source exposures to allow us to precisely estimate exposure date. The incubation 
period ranged from 2-11 days for confirmed secondary cases and 0-11 days for probable and 
confirmed combined, suggesting that current advice around isolation of contacts for 14 days after 
exposure is appropriate. The mean time from onset in the primary case to exposure among 
confirmed secondary cases was 1.33 days, suggesting that cases are most infectious soon after 
symptom onset. Though it should be noted that, at the time, contact tracing from the time of 
symptom onset in the index case, not before symptom onset. 
 
A systematic review and meta-analysis by Viner et al (2020) examined susceptibility of children to 
SARS-CoV-2 and their role in transmission (28). The pooled estimated odds of being an infected 
contact among children compared to adults was 0.44 (95%CI 0.29-0.69). When restricted to 
household transmission studies alone, the pooled estimate was 0.19 (95% CI 0.10-0.36). While we 
see lower SARs among contacts who are children, this was only significant in the analysis that was 
restricted to confirmed secondary cases. When probable secondary cases were included the effect 
was no longer significant. This may reflect milder symptoms and a lower propensity for testing 
children, in which case previous estimates, with more stringent case definitions, in particular those 
relying on PCR confirmed cases alone would underestimate SARs in children. The review found no 
studies that reported SARs where children were the primary case. A review of household clusters by 
Zhu et al (2020) found that only 3 out of 31 household transmission clusters had a child as the index 
case, and suggested that children do not play a substantive role in transmission. Nevertheless, the 
low number of households with children as the index may be due to lower ascertainment in children 
if they are less likely to present with symptoms (29). However, recent evidence suggests that 
children carry higher levels of COVID-19 genetic material in their nose and throat than adults which 
would support our findings of a higher secondary attack rate among household contacts of 
children(30). Furthermore, a recent study from South Korea found that the highest proportion of 
positive household contacts by the age of the index case was among contacts of index cases aged 
10-19 years of age (31). Nevertheless, the South Korean study did not identify whether index cases 
were the primary case therefore we do not know the direction of transmission. 
 
Our study has a number of strengths: this is one of the largest COVID-19 household studies 
published to date and one of the only studies outside of Asia. Data was collected through direct 
patient interviews and high rates of follow-up were achieved with good data completeness, 
household contacts were actively followed up by local health protection teams on a daily basis to 
monitor symptoms. We identified point source case-secondary case pairs which allowed us to 
directly estimate the incubation period without having to model timing of infection. The study also 
has a number of limitations: test results were not available for some participants who developed 
symptoms, therefore we likely under-ascertained confirmed secondary cases. Furthermore, as with 
previous studies, testing was focussed on those who develop symptoms. Estimates of asymptomatic 
infection range from 4% to 41%, therefore we are likely to have missed asymptomatic cases (32). 
Furthermore, rates of asymptomatic infection appear to be highest in children, therefore we 
particularly underestimate secondary infection rates in children (29, 32). We are currently 
undertaking further analyses of household transmission incorporating swabbing of asymptomatics 
and serology which will provide a better understanding of true secondary infection rates and 
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asymptomatic infection. We are also limited in our ability to draw any clear conclusions about 
transmission from children due to the small number of households with a child as a primary case. 
 
Since the early stages of the pandemic, data from the FF100 study has been shared in real-time with 
independent modelling groups advising government and has informed policy making and public 
health management guidance. The high household SAR and the lack of transmission in a range of 
other settings highlight the importance of the household setting for onwards transmission. This 
emphasises the need for hygiene measures within the household and, where there are vulnerable 
members of the household, maintaining distancing within the household, in particular if a household 
member develops symptoms. While numbers are small, the high household SARs from paediatric 
primary cases suggest that reopening of schools needs careful monitoring for evidence of 
transmission from children in this setting. 
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